logo
Is It Too Late To Consider Buying Dillard's, Inc. (NYSE:DDS)?

Is It Too Late To Consider Buying Dillard's, Inc. (NYSE:DDS)?

Yahoo6 hours ago

Dillard's, Inc. (NYSE:DDS), is not the largest company out there, but it received a lot of attention from a substantial price increase on the NYSE over the last few months. While good news for shareholders, the company has traded much higher in the past year. As a well-established company, which tends to be well-covered by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. But what if there is still an opportunity to buy? Today we will analyse the most recent data on Dillard's's outlook and valuation to see if the opportunity still exists.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
Good news, investors! Dillard's is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is $502.95, but it is currently trading at US$400 on the share market, meaning that there is still an opportunity to buy now. However, given that Dillard's's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
View our latest analysis for Dillard's
Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected over the next couple of years, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Dillard's, at least in the near future.
Are you a shareholder? Although DDS is currently undervalued, the negative outlook does bring on some uncertainty, which equates to higher risk. Consider whether you want to increase your portfolio exposure to DDS, or whether diversifying into another stock may be a better move for your total risk and return.
Are you a potential investor? If you've been keeping tabs on DDS for some time, but hesitant on making the leap, we recommend you research further into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.
With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that Dillard's has 1 warning sign and it would be unwise to ignore this.
If you are no longer interested in Dillard's, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Seveno Capital and Borderless Healthcare Group launch JV to provide ‘medical wellness service' to hospitality owners
Seveno Capital and Borderless Healthcare Group launch JV to provide ‘medical wellness service' to hospitality owners

Business Wire

timean hour ago

  • Business Wire

Seveno Capital and Borderless Healthcare Group launch JV to provide ‘medical wellness service' to hospitality owners

SINGAPORE--(BUSINESS WIRE)-- Seveno Capital and Borderless Healthcare Group have launched the world's first medical wellness real estate company to target the growing $1.8 trillion global wellness market as the world enters a 'longevity boom' that UBS reports will be worth US$8 trillion by 2030. The Well Estate will provide a turnkey solution for hospitality asset owners to be able to offer transformative medical wellness experiences to guests as the global hospitality industry seeks to harness the US$1.8 trillion global wellness boom. Share The Well Estate will support hotel and hospitality asset owners to shift from a 'room yield' to a 'room plus' business model by providing turnkey medical wellness solutions that give guests live access to health and medical experts as well as famous content creators. Guests will also have access to personalised diets, fitness, yoga, mindfulness and health programs. The Well Estate solution will unlock new revenue channels for hospitality asset owners that will drive higher transaction value per stay, longer guest retention and full utilization of underperforming facilities like gyms and spas. The new company will focus on asset owners within the 'wellness archipelago' of Singapore, Thailand, Indonesia, Vietnam and Malaysia. The global wellness industry is booming, valued at $5.6 trillion in 2023 and projected to reach $8.5 trillion by 2027, according to the Global Wellness Institute. The wellness economy is also expected to grow by 8.6% annually through 2027, outpacing global GDP. Hotels are playing a growing role, with wellness tourism accounting for $651 billion globally in 2022 and expected to hit $1.4 trillion by 2027. Travelers increasingly seek wellness experiences, with over 50% preferring hotels that offer spa, fitness, and nutrition services. Luxury wellness resorts can generate 30–50% higher daily rates than traditional hotels. Hotels are investing heavily to meet this demand and to capture a larger share of this lucrative market; integrating labs, diagnostics, IV drips and longevity hubs into their amenities. The Well Estate is a JV between Borderless Healthcare Group, led by global healthcare technology, media, telecommunication, service and content pioneer Dr Wei Siang Yu; and Seveno Capital, led by Park Hotel Group founder and healthspan entrepreneur, Allen Law. Allen Law said: 'The Well Estate will enable hospitality asset owners to align their business and guest offering with the global wellness and longevity revolution that will be equally as transformative as AI.' Dr Wei said: 'This represents a new phase for the hospitality sector and a new benchmark for immersive guest experiences that are profitable, purposeful and scalable.'

US Approves Sale of $2 Billion in Military Hardware to Australia
US Approves Sale of $2 Billion in Military Hardware to Australia

Bloomberg

timean hour ago

  • Bloomberg

US Approves Sale of $2 Billion in Military Hardware to Australia

The US State Department has signed off on the potential sale of military hardware to Australia valued at an estimated $2 billion (A$3.1 billion), including fighter jet spare parts. Australia had asked to buy equipment and services for its Boeing F/A-18F Super Hornet fighter jet, and the electronic attack aircraft EA-18G Growler which can disrupt, deceive or deny a broad range of military electronic systems.

Stock hits new all-time high as Israel-Iran conflict escalates
Stock hits new all-time high as Israel-Iran conflict escalates

Yahoo

timean hour ago

  • Yahoo

Stock hits new all-time high as Israel-Iran conflict escalates

Stock hits new all-time high as Israel-Iran conflict escalates originally appeared on TheStreet. Circle Internet Group (NYSE: CRCL), the crypto company behind the USDC stablecoin, opened to an all-time high (ATH) of $165.60 on June 16 as the Israel-Iran conflict entered into its fourth day. As reported earlier, Circle earlier reportedly rejected acquisition bids by crypto industry giants such as Ripple and Coinbase (Nasdaq: COIN). It later made an impressive IPO debut on June 5 as it opened at $69, 124.19% above the IPO price of $31. The IPO was underwritten by a group of Wall Street giants, including JP Morgan Chase, Citigroup, and Goldman Sachs. The previous CRCL ATH was around $138 which it hit a week ago. In fact, its trading was halted multiple times due to limit up-limit down rules due to a stock's price or trading volumes experiencing extreme volatility. Circle is the company behind the U.S. dollar-pegged USDC stablecoin. It is a type of cryptocurrency that attempts to keep its price stable, unlike traditionally volatile cryptocurrencies such as Bitcoin. As per DeFiLlama, the stablecoin market is worth $251.75 billion, with USDC accounting for more than 23% of the market share. Recently, Circle CEO Jeremy Allaire hailed stablecoins as "the highest utility form of money ever created." Though the industry is not yet at its "iPhone moment," when developers realized the potential of programmable mobile devices, it will soon realize the power of programmable digital dollars, Allaire added. At press time, CRCL was trading at $157.07 at the time of writing, up 17.60% a day. Stock hits new all-time high as Israel-Iran conflict escalates first appeared on TheStreet on Jun 16, 2025 This story was originally reported by TheStreet on Jun 16, 2025, where it first appeared. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store